マイクロフルイディクスの世界市場2022:セラミック、高分子、チップ、ポンプ、ニードル、用途

◆英語タイトル:Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022
◆発行会社/調査会社:RNCOS
◆商品コード:RNCS704004
◆発行日:2017年3月14日
◆調査対象地域:グローバル
◆産業分野:材料
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,600 ⇒換算¥180,800見積依頼/購入/質問フォーム
Multi UserUSD2,700 ⇒換算¥305,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[マイクロフルイディクスの世界市場2022:セラミック、高分子、チップ、ポンプ、ニードル、用途]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report “Microfluidics Market – By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022” studies the market for the application of microfludics in pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.
On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

According to analysis, the market for microfluidic devices all over the world was worth US$ 3 Billion in 2016, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2016, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2016. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

*** レポート目次(コンテンツ)***

1. Analyst View
2. Research Methodology
3. Microfluidics – An Introduction
4. Microfluidics Market Overview
4.1 Microfluidics Market
4.2 Healthcare Microfluidics Market
5. Drivers & Challenges
5.1 Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Increasing Demand of Point of Care Diagnostics
5.1.3 Rising Application in Life Sciences Research
5.1.4 Benefits of Miniaturization of Chip
5.2 Challenges
5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
5.2.2 Ambiguous Regulatory Framework
5.2.3 Lack of Awareness in Emerging Markets
6. Market Segmentation
6.1 By Material
6.1.1 Ceramics
6.1.2 Polymers
6.1.3 Others
6.2 By Components
6.2.1 Microfluidics Chips Based Microfluidic Devices
6.2.2 Microfluidics Pumps Based Microfluidic Devices
6.2.3 Microfluidics Needles Based Microfluidic Devices
6.2.4 Others
6.3 By Applications
6.3.1 In–Vitro Diagnostics
6.3.2 Pharmaceutical & Life Sciences Research
6.3.3 Drug Delivery
6.3.4 Others
6.4 By Geography
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Rest of the World
7. Regulatory Scenario
7.1 US+G2
7.2 Europe
7.3 Asia-Pacific
7.3.1 India
7.3.2 China
8. Trends & Developments
8.1 Grants Announced for Microfluidics Research
8.2 Mergers & Acquisitions
9. Competitive Assessment
9.1 Fluidigm Corporation
9.2 F. Hoffmann-La Roche Ltd.
9.3 Bio-Rad Laboratories, Inc.
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 Perkin Elmer, Inc.
9.7 Illumina, Inc.
9.8 Shimadzu Corporation
9.9 Danaher Corporation
9.10 Abbott

List of Figures:

Figure 4-1: Global – Microfluidics Market (Billion US$), 2016-2022
Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2016 & 2022
Figure 4-3: Global – Healthcare Microfluidics Market (Billion US$), 2016-2022
Figure 6-1: Global Microfluidics Market by Material (%), 2016
Figure 6-2: Global – Ceramics Market for Microfluidics (Billion US$), 2016-2022
Figure 6-3: Global – Polymers Market for Microfluidics (Billion US$), 2016-2022
Figure 6-4: Global – Others Market for Microfluidics (Billion US$), 2016-2022
Figure 6-5: Global – Microfluidics Market by Components (%), 2016
Figure 6-6: Global – Microfluidics Chip Based Microfluidics Market (Billion US$), 2016-2022
Figure 6-7: Global – Microfluidics Pumps Based Microfluidics Market (Billion US$), 2016-2022
Figure 6-8: Global – Microfluidics Needles Based Microfluidics Market (Billion US$), 2016-2022
Figure 6-9: Global – Other Microfluidic Components Market (Billion US$), 2016-2022
Figure 6-10: Global – Microfluidics Market by Applications (%), 2016
Figure 6-11: Global – Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2016-2022
Figure 6-12: Global – Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2016-2022
Figure 6-13: Global – Microfluidics Market for Drug Delivery (Billion US$), 2016-2022
Figure 6-14: Global – Microfluidics Market for Other Applications (Billion US$), 2016-2022
Figure 6-15: Global – Microfluidics Market by Geography (%), 2016
Figure 6-16: North America – Microfluidics Market (Billion US$), 2016-2022
Figure 6-17: Europe – Microfluidics Market (Billion US$), 2016-2022
Figure 6-18: Asia Pacific – Microfluidics Market (Billion US$), 2016-2022
Figure 6-19: Rest of the World – Microfluidics Market (Billion US$), 2016-2022
Figure 9-1: Fluidigm Corporation – Revenue Breakup by Business Segment (%), 2016
Figure 9-2: Fluidigm Corporation – Revenue Breakup by Geography (%), 2016
Figure 9-3: F. Hoffmann-La Roche Ltd. – Revenue Breakup by Business Segment (%), 2016
Figure 9-4: F. Hoffmann-La Roche Ltd. – Revenue Breakup by Geography (%), 2016
Figure 9-5: Bio-Rad Laboratories, Inc. – Revenue Breakup by Business Segment (%), 2015
Figure 9-6: Bio-Rad Laboratories, Inc. – Revenue Breakup by Geography (%), 2015
Figure 9-7: Thermo Fisher Scientific, Inc. – Revenue Breakup by Business Segment (%), 2016
Figure 9-8: Agilent Technologies, Inc. – Revenue Breakup by Geography (%), 2016
Figure 9-9: PerkinElmer – Revenue Breakup by Geography (%), 2015
Figure 9-10: Illumina Inc. – Revenue Breakup by Geography (%), 2016
Figure 9-11: Shimadzu Corporation – Revenue Break up by Geography (%), 2015
Figure 9-12: Danaher Corporation – Breakup of Sales by Geography (%), 2015
Figure 9-13: Abbott – Revenue Breakup by Geography (%), 2015

List of Tables:

Table 5-1: Cost Involved in Microfluidics Chips Manufacturing
Table 6-1: Global – Cancer Incidences (Million), 2015 & 2025
Table 6-2: North America – Cancer Incidences (Million), 2015 & 2025
Table 6-3: Europe – Cancer Incidences (Million), 2015 & 2025
Table 6-4: Asia Pacific – Cancer Incidences (Million), 2015 & 2025
Table 6-5: Rest of the World – Cancer Incidences (Million), 2015 & 2025
Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
Table 9-1: Fluidigm Corporation – Company Financials (Billion US$), 2014-2016
Table 9-2: F. Hoffmann-La Roche Ltd. – Company Financials (Billion US$), 2014-2016
Table 9-3: Bio-Rad Laboratories, Inc. – Company Financials (Billion US$), 2013-2015
Table 9-4: Thermo Fisher Scientific, Inc. – Company Financials (Billion US$), 2014-2016
Table 9-5: Agilent Technologies, Inc. – Company Financials (Million US$), 2014- 2016
Table 9-6: Perkin Elmer, Inc. – Company Financials (Million US$), 2014- 2016
Table 9-7: Illumina, Inc. – Company Financials (Million US$), 2014- 2016
Table 9-8: Shimadzu Corporation – Company Financials (Million US$), 2013- 2015
Table 9-9: Danaher Corporation – Company Financials (Million US$), 2013- 2015
Table 9-10: Abbott – Company Financials (Million US$), 2013 – 2015



*** レポートのキーワード ***

マイクロフルイディクス、マイクロフルイディクス材料、セラミック、高分子、マイクロフルイディクスチップ、マイクロフルイディクスポンプ、マイクロフルイディクスニードル、マイクロフルイディクス用途

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(RNCS704004 )"マイクロフルイディクスの世界市場2022:セラミック、高分子、チップ、ポンプ、ニードル、用途" (英文:Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022)はRNCOS社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。